Read + Share
Shi M, Li L, Wang S, Cheng H, et al. Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for
relapsed/refractory acute lymphoblastic leukemia. Am J Hematol 2022 Feb 18. doi: 10.1002/ajh.26506.
PMID: 35179242
|
 |
|
Shi M, Li L, Wang S, Cheng H, et al. Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for
relapsed/refractory acute lymphoblastic leukemia. Am J Hematol 2022 Feb 18. doi: 10.1002/ajh.26506.
PMID: 35179242
|
|
|
|